Literature DB >> 9251105

Ornithine decarboxylase activity in cerebral post-ischemic reperfusion damage: effect of methionine sulfoximine.

C Di Giacomo1, V Sorrenti, R Acquaviva, A Campisi, G Vanella, J R Perez-Polo, A Vanella.   

Abstract

Excessive activation of glutamate receptors via the N-methyl-D-aspartate (NMDA) subtype appears to play a role in the sequence of cellular events which lead to irreversible ischemic damage to neurons. Furthermore, NMDA receptor activation induces a stimulation of ornithine decarboxylase (ODC), the rate-limiting enzyme for polyamine (PA) biosynthesis. In order to better understand the role of PA we have measured ODC activity and the effect of methionine sulfoximine (MSO), a molecule able to stimulate ODC, on a model of transient cerebral ischemia. There was a significant increase in ODC activity in the rat cerebral cortex during post-ischemic reperfusion. The treatment with MSO induced a significant decrease in cerebral glutamine synthetase activity accompanied by a marked increase in ODC activity. In MSO-pretreated rats there was a significant decrease in the survival rate when compared to untreated ischemic rats.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9251105     DOI: 10.1023/a:1027321420075

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  46 in total

1.  Autoreceptor regulation of glutamate and aspartate release from slices of the hippocampal CA1 area.

Authors:  D Martin; G A Bustos; M A Bowe; S D Bray; J V Nadler
Journal:  J Neurochem       Date:  1991-05       Impact factor: 5.372

2.  Presynaptic NMDA receptors stimulate noradrenaline release in the cerebral cortex.

Authors:  K Fink; H Bönisch; M Göthert
Journal:  Eur J Pharmacol       Date:  1990-08-21       Impact factor: 4.432

3.  Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus.

Authors:  A Pittaluga; M Raiteri
Journal:  Eur J Pharmacol       Date:  1990-11-27       Impact factor: 4.432

4.  Protein kinase C as an early and sensitive marker of ischemia-induced progressive neuronal damage in gerbil hippocampus.

Authors:  K Domańska-Janik; B Zabłocka
Journal:  Mol Chem Neuropathol       Date:  1993-10

5.  Effects of polyamine synthesis blockade on neuronal loss and astroglial reaction after transient forebrain ischemia.

Authors:  M Zoli; I Zini; R Grimaldi; G Biagini; L F Agnati
Journal:  Int J Dev Neurosci       Date:  1993-04       Impact factor: 2.457

6.  Presynaptic glutamate receptors modulate dopamine release from striatal synaptosomes.

Authors:  J K Wang
Journal:  J Neurochem       Date:  1991-09       Impact factor: 5.372

7.  Regulation of N-methyl-D-aspartate receptor-mediated calcium transport and norepinephrine release in rat hippocampus synaptosomes by polyamines.

Authors:  F Siddiqui; Z Iqbal
Journal:  Neurochem Res       Date:  1994-11       Impact factor: 3.996

8.  N-methyl-D-aspartate releases excitatory amino acids in rat corpus striatum in vivo.

Authors:  A M Young; H F Bradford
Journal:  J Neurochem       Date:  1991-05       Impact factor: 5.372

9.  The polyamine synthesis inhibitor alpha-difluoromethylornithine is neuroprotective against N-methyl-D-aspartate-induced brain damage in vivo.

Authors:  S J Kish; J M Wilson; P J Fletcher
Journal:  Eur J Pharmacol       Date:  1991-12-10       Impact factor: 4.432

10.  Polyamine inhibition of lipoperoxidation. The influence of polyamines on iron oxidation in the presence of compounds mimicking phospholipid polar heads.

Authors:  B Tadolini
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

View more
  1 in total

1.  Effect of Treatment with Cyanidin-3-O-β-D-Glucoside on Rat Ischemic/Reperfusion Brain Damage.

Authors:  Claudia Di Giacomo; Rosaria Acquaviva; Rosa Santangelo; Valeria Sorrenti; Luca Vanella; Giovanni Li Volti; Nicolantonio D'Orazio; Angelo Vanella; Fabio Galvano
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-13       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.